Companies: 10,795·Total market cap: $144.5T
SciSparc Ltd.

SciSparc Ltd.

SPRCNASDAQHealthcare● Active
$9.87
$-0.55(-5.28%)
Market Cap$570871
P/E Ratio
52W High$80.1
52W Low$2.98

SciSparc Ltd. (SPRC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

sprc · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for SciSparc Ltd. (SPRC) measures how much investors pay for each dollar of the company's trailing earnings. SPRC's current PE ratio of N/A is calculated by dividing its stock price of $9.87 by its TTM earnings per share of -$299.95.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
296.40x
FY2025 est. EPS $0.03
Based on 1 analyst
EPS (TTM)
-$299.95
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SciSparc Ltd. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
SciSparc Ltd.
SciSparc Ltd.You
SPRC
$1MN/A-$299.95
Artelo Biosciences, Inc.
Artelo Biosciences, Inc.
ARTL
$3MN/A-$5.47
Azitra, Inc.
Azitra, Inc.
AZTR
$2MN/A-$2.25
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc.
INDP
$4MN/A-$21.58
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.
JSPR
$7MN/A-$3.95
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc.
LIPO
$0MN/A-$4.79
Onconetix, Inc.
Onconetix, Inc.
ONCO
$0MN/A-$4.28

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.88
2024-12-31
FY2024
$-9.71
2023-12-31
FY2023
$-25.97
2022-12-31
FY2022
$-26.68
2021-12-31
FY2021
$-66.36
2020-12-31
FY2020
$0.00
2019-12-31
FY2019
$0.00
2018-12-31
FY2018
$0.00
2017-12-31
FY2017
$0.00
2016-12-31
FY2016
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for SciSparc Ltd. (SPRC) measures how much investors pay for each dollar of the company's trailing earnings. SPRC's current PE ratio of N/A is calculated by dividing its stock price of $9.87 by its TTM earnings per share of -$299.95.

PE Ratio = Stock Price ÷ EPS (TTM)
= $9.87 ÷ -$299.95 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SPRC pe ratio · 6 questions

SPRC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $9.87 and TTM EPS of -$299.95. Data sourced from Financial Modeling Prep via SPRC's SEC 10-K and 10-Q filings.

SPRC PE ratioWhat is SPRC PE ratioCurrent PE ratio of SPRCSPRC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SciSparc Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09